Clinical impact of treatment delay in pancreatic cancer patients revisited

János György Pitter¹, Gábor Lukács^{2

3}, Marcell Csanádi¹, Zoltán Vokó^{1

4}

Affiliations

¹ Syreon Research Institute, Budapest, Hungary.
² Department of Oncology, Móritz Kaposi General Hospital, Kaposvár, Hungary.
³ Doctoral School, Faculty of Health Sciences, University of Pécs, Pécs, Hungary.
⁴ Department of Health Policy and Health Economics, Eötvös Loránd University, Budapest, Hungary.

Comment

János György Pitter et al. Int J Cancer. 2018.

. 2018 Jun 15;142(12):2621-2622.

doi: 10.1002/ijc.31263. Epub 2018 Jan 31.

János György Pitter¹, Gábor Lukács^{2

3}, Marcell Csanádi¹, Zoltán Vokó^{1

4}

¹ Syreon Research Institute, Budapest, Hungary.
² Department of Oncology, Móritz Kaposi General Hospital, Kaposvár, Hungary.
³ Doctoral School, Faculty of Health Sciences, University of Pécs, Pécs, Hungary.
⁴ Department of Health Policy and Health Economics, Eötvös Loránd University, Budapest, Hungary.

No abstract available

Comment in

Author's reply to : Pancreatic cancer : Extension of tumor is associated with timeliness of care and with survival in a population-based study.
Jooste V, Bouvier AM. Jooste V, et al. Int J Cancer. 2018 Jun 15;142(12):2623. doi: 10.1002/ijc.31264. Epub 2018 Jan 31. Int J Cancer. 2018. PMID: 29344936 No abstract available.

Pancreatic cancer: Wait times from presentation to treatment and survival in a population-based study.
Jooste V, Dejardin O, Bouvier V, Arveux P, Maynadie M, Launoy G, Bouvier AM. Jooste V, et al. Int J Cancer. 2016 Sep 1;139(5):1073-80. doi: 10.1002/ijc.30166. Epub 2016 May 14. Int J Cancer. 2016. PMID: 27130333